Democrat McCall, who ran unsuccessfully for governor last fall, says he will continue to advocate corporate governance reform as vice chairman of HealthPoint, a private equity firm that focuses on the orthopedics industry. New Yorkbased HealthPoint expects to raise a fund of $400 million by June. McCall vows that when placing investments he will push for the same “high standards of ethical corporate governance practices” that he championed as comptroller. “Before, I was able to exert influence. Now I am actually going to be in a controlling position to make sure that all those companies have the best possible corporate governance.” McCall has other posts that give him a chance to face corporate governance issues head-on: He was recently appointed to Tyco International’s board of directors and last month was reelected to a two-year term on the New York Stock Exchange board, where he is on the committee addressing internal governance matters. “Obviously, the NYSE recognizes that its corporate governance practices must be in line with those it is imposing on the corporate community,” he says. “We will be putting into place a set of practices that will be exemplary.”
